How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Peripheral Interventional Guidewires Market
- By Guidewire Coating Material: Hydrophilic Coating, Hydrophobic Coating, Polymer Coating, PTFE Coating, Silicone Coating
- By Guidewire Core Material: Stainless Steel Core, Nitinol Core, Hybrid Core (Stainless Steel + Nitinol)
- By Guidewire Tip Configuration: Straight Tip, Angled Tip, J-Tip, Floppy Tip, Tapered Tip
- By Guidewire Diameter: 0.014 inch, 0.018 inch, 0.025 inch, 0.035 inch
- By Application Type: Peripheral Vascular Interventions, Neurovascular Interventions, Coronary Interventions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hydrophilic Coating leads By Guidewire Coating Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Peripheral Interventional Guidewires Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Cook Medical (a subsidiary of Medtronic)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Asahi Intecc Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cordis (a Cardinal Health company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Teleflex Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →C.R. Bard (now part of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Shanghai Shape Memory Alloy Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →LivaNova PLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MicroPort Scientific Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hydrophilic Coating54.5
- Hydrophobic Coating7.9
- Polymer Coating13.5
- PTFE Coating16.7
- Silicone Coating7.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Abbott Laboratories23.8
- Boston Scientific Corporation10.0
- Medtronic plc6.4
- Terumo Corporation11.9
- Cook Medical (a subsidiary of Medtronic)15.1
- Asahi Intecc Co. Ltd.4.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe23.8
- Asia Pacific22.6
- Latin America12.2
- Middle East and Africa9.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 81 | 78 | 91 | 74 | 91 | 84 | 83 |
| Boston Scientific Corporation | 88 | 86 | 69 | 91 | 83 | 74 | 82 |
| Medtronic plc | 83 | 72 | 70 | 87 | 75 | 68 | 76 |
| Terumo Corporation | 77 | 82 | 59 | 82 | 73 | 66 | 73 |
| Cook Medical (a subsidiary of Medtronic) | 62 | 59 | 56 | 71 | 65 | 67 | 63 |
| Asahi Intecc Co. Ltd. | 51 | 68 | 63 | 71 | 57 | 55 | 61 |
| Cordis (a Cardinal Health company) | 43 | 40 | 41 | 52 | 43 | 42 | 44 |
| B. Braun Melsungen AG | 37 | 52 | 55 | 42 | 49 | 57 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Abbott Laboratories | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Boston Scientific Corporation | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Medtronic plc | ✓ | ✓ | ◐ | ◐ | ✓ | − |
| Terumo Corporation | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Cook Medical (a subsidiary of Medtronic) | ◐ | ◐ | − | ◐ | ◐ | − |
| Asahi Intecc Co. Ltd. | − | ◐ | ◐ | ◐ | − | ◐ |
| Cordis (a Cardinal Health company) | − | ◐ | − | − | − | − |
| B. Braun Melsungen AG | − | ◐ | ◐ | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Guidewire Coating Material in North America, then scale across Peripheral Interventional Guidewires Market — a $429M beachhead inside a $6.30B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Hydrophilic Coating
Best fit — highest urgency & budget in Guidewire Coating Material.
Hydrophobic Coating
Strong fit — clear ROI and a fast path to value.
Polymer Coating
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Guidewire Coating Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Guidewire Core Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Guidewire Tip Configuration
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Guidewire Coating Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Peripheral Interventional Guidewires Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Peripheral Interventional Guidewires Market is a high-growth opportunity — $7.63B by 2033, compounding at 10.7%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.7% CAGR
Demand compounds through 2033, outpacing GDP across Guidewire Coating Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Guidewire Coating Material moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Guidewire Core Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Peripheral Interventional Guidewires Market — a $10.7B market by 2033. Plan: grow share from 8.8% to 14.8%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.8% | 14.8% | Behind |
| Revenue | $863M | $1.59B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 35.1% | 39.9% | Ahead |
| Customer retention | 87.4% | 96.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Guidewire Coating Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Guidewire Core Material capability
A defensible second engine — invest in Guidewire Core Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Guidewire Coating Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Guidewire Core Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $190M capacity & capability investment
- Greenlight bolt-on M&A in Guidewire Core Material
- Authorise North America expansion plan
- Fund R&D program for Guidewire Coating Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentAt risk
Sales deck · value proposition
Win the Peripheral Interventional Guidewires Market conversation — a $4.96B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Guidewire Coating Material
Goal Grow share in Guidewire Coating Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Peripheral Interventional Guidewires Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Peripheral Interventional Guidewires Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Peripheral Interventional Devices Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportPeripheral Imaging Catheter Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportPeripheral Guide Wires Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportPeripheral Embolization Devices Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportPeripheral Drug-eluting Balloon Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportPeripheral Drug-Coated Balloon Market
Market size, share, segmentation and regional forecast.
$363M market · 2025 base year
View reportPeripheral Circulatory Disease Medications Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportPeripheral Chronic Total Occlusion Device Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportPeripheral Catheterization Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportPeripheral Blood Mononuclear Cells (PBMC) Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPeripheral Balloon Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportPeripheral Balloon Dilation Catheter Market
Market size, share, segmentation and regional forecast.
$600M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy